Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Proteomics and disease: opportunities and challenges.

Maria Kavallaris1, Glenn M Marshall

  • 1Experimental Therapeutics Program, Children's Cancer Institute Australia for Medical Research, Sydney, NSW. m.kavallaris@ccia.unsw.edu.au

The Medical Journal of Australia
|June 9, 2005
PubMed
Summary

Proteomics, the study of proteins, is advancing disease research by identifying disease-related proteins. This field offers potential for new diagnostics, prognostics, and tailored therapies, despite ongoing technical challenges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer.

NPJ genomic medicine·2026
Same author

The myeloid cell leukaemia-1 inhibitor MIK665 is a potent therapy in preclinical models of paediatric acute myeloid leukaemia.

British journal of haematology·2026
Same author

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Nature communications·2026
Same author

βIII-tubulin can act as a brake on extrinsic apoptosis in pancreatic cancer.

Cell death & disease·2026
Same author

High School Cancer Experience and Age at Diagnosis: Perspectives of Adolescents, Young Adults, and Parents.

Journal of adolescent and young adult oncology·2026
Same author

Correction: Targeted Therapy of TERT-Rearranged Neuroblastoma with BET Bromodomain Inhibitor and Proteasome Inhibitor Combination Therapy.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Genomics

Background:

  • Following the human genome sequencing, research focus shifted to understanding gene products, specifically proteins.
  • Proteomics, the large-scale study of protein structure and function, has emerged as a critical field.
  • Disease proteomics specifically targets proteins implicated in human diseases.

Purpose of the Study:

  • To explore the role of proteomics in understanding human diseases.
  • To highlight the potential of proteomics in identifying diagnostic and therapeutic targets.
  • To discuss the challenges and future directions in the field of disease proteomics.

Main Methods:

  • Large-scale study of protein structure and function.
  • Identification of proteins involved in human disease.

Related Experiment Videos

  • Analysis of protein expression, structure, and function in disease contexts.

    • Main Results:

    • Proteomics has identified promising protein markers for various diseases, including cancer, transplant rejection, tuberculosis, and malaria.
    • The field shows potential for developing patient-tailored therapies.
    • Identified proteins can serve as diagnostic or prognostic markers.

    Conclusions:

    • Proteomics is a rapidly evolving field with significant potential to impact human health.
    • Despite technical challenges in detecting low-abundance proteins and managing complex data, proteomics offers new avenues for disease understanding and treatment.
    • Further advancements in proteomics are expected to yield personalized therapeutic strategies.